ClinicalTrials.gg
Not yet recruitingNCT07749898SMET-LBPUpdated Nov 18, 2026

Spinal Mobilization Added to Exercise Therapy for Chronic Non-Specific Low Back Pain

An interventional study of Spinal Mobilization and Standard Exercise Therapy in Non-Specific Low Back Pain, sponsored by Biruni University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Biruni University · Not applicable, Interventional, and Treatment

Updated Nov 18, 2026Start date movedPrimary completion moved+6 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 295 studies in Low Back Pain with a site in Turkey — 63 open to participants now, 73 under way, none of them phase 3. Low Back Pain · Turkey.

Planned enrollment
68th of 212
60 · median 50
Started
2026
with 37 others
No phase
204 of 295
42 open now
Primary completion
2027-02
later than 63 of 72 live
Registered
282nd of 295
by date

Among the 295 studies in Low Back Pain with a site in Turkey, this one is the 68th largest by planned enrollment of the 212 interventional ones that give a count, is one of 38 that started in 2026, is one of 204 with no phase, reaches primary completion later than 63 of the 72 other live ones, and was the 282nd registered.

Low Back Pain

2,929 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

63 of the 295 studies in Low Back Pain with a site in Turkey are open now. Recruiting first, the newest first:

58 more — sign in →

All 63 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 295 studies in Low Back Pain with a site in Turkey, or all of them as a file.
02

Study summary

Chronic non-specific low back pain is a major cause of functional disability and reduced quality of life worldwide. Although exercise therapy is widely recommended for managing chronic low back pain, the additional benefits of spinal mobilization on functional disability, pain intensity, and fear-avoidance beliefs remain unclear.

This assessor-blinded randomized controlled trial aims to investigate the effects of spinal mobilization added to standard exercise therapy on functional disability, pain intensity, fear-avoidance beliefs, and lumbar range of motion in individuals with chronic non-specific low back pain.

A total of 60 participants aged 18-60 years will be randomly allocated to either a standard exercise therapy group or a standard exercise therapy plus spinal mobilization group. Both groups will participate in a six-week standardized exercise program, while the intervention group will additionally receive non-thrust spinal mobilization once weekly.

Outcome assessments will be conducted at baseline, after the six-week intervention, and three months following treatment completion. The primary outcome will be functional disability measured using the Roland-Morris Disability Questionnaire. Secondary outcomes will include pain intensity, fear-avoidance beliefs, and lumbar range of motion.

The findings may provide evidence regarding the additional and sustained effects of spinal mobilization when combined with standard exercise therapy in individuals with chronic non-specific low back pain.

Read the detailed description

Background Chronic non-specific low back pain is one of the leading causes of disability worldwide and is associated with substantial physical, psychological, and socioeconomic burden. Exercise therapy is widely recommended as a primary conservative treatment approach, while spinal mobilization is frequently used as an adjunctive intervention. However, evidence regarding the additional and sustained benefits of spinal mobilization when combined with standardized exercise therapy remains limited.

Objective The aim of this randomized controlled trial is to investigate the effects of spinal mobilization added to standard exercise therapy on functional disability, pain intensity, fear-avoidance beliefs, and lumbar range of motion in individuals with chronic non-specific low back pain. Additionally, the study aims to evaluate whether the effects are maintained three months after treatment completion.

Methods This single-center, assessor-blinded, two-arm randomized controlled trial will include 60 participants aged 18-60 years with chronic non-specific low back pain lasting at least 12 weeks. Participants will be randomly allocated in a 1:1 ratio to either a standard exercise therapy group (n=30) or a standard exercise therapy plus spinal mobilization group (n=30).

Both groups will receive the same six-week standardized exercise and education program, consisting of three exercise sessions per week (two supervised sessions and one home-based session). Each session will last approximately 45-60 minutes and include trunk motor control exercises, strengthening exercises, lumbar mobility exercises, functional lower extremity exercises, and walking.

The intervention group will additionally receive non-thrust spinal mobilization targeting the lumbar or lumbopelvic region, performed by a trained physiotherapist once weekly for six weeks. Each mobilization session will last approximately 10-15 minutes. High-velocity, low-amplitude spinal manipulation will not be performed.

Functional disability will be assessed using the Roland-Morris Disability Questionnaire (RMDQ), pain intensity using the Visual Analog Scale (VAS), fear-avoidance beliefs using the Fear-Avoidance Beliefs Questionnaire (FABQ), and lumbar range of motion using standardized measurements.

Outcome assessments will be conducted at baseline (Week 0), immediately after the six-week intervention (Week 6), and three months after treatment completion (approximately Week 18).

The primary outcome will be functional disability measured by the RMDQ at Week 6. Secondary outcomes will include pain intensity, fear-avoidance beliefs, lumbar range of motion, treatment adherence, and adverse events.

The primary analysis will compare RMDQ scores between groups at Week 6 using analysis of covariance (ANCOVA), adjusting for baseline RMDQ scores. Repeated measurements across the three assessment points will be analyzed using an appropriate mixed-effects model.

Expected Outcomes

It is hypothesized that adding spinal mobilization to standard exercise therapy will result in greater improvements in functional disability compared with standard exercise therapy alone. The study will also investigate potential additional benefits regarding pain intensity, fear-avoidance beliefs, and lumbar range of motion, as well as the maintenance of treatment effects during the three-month follow-up period.

03

Conditions studied

  • Non-Specific Low Back Pain

Browse trials for

Keywords

  • Spinal Mobilization
  • Chronic Non-Specific Low Back Pain
  • Exercise Therapy
  • Functional Disability
  • Fear-Avoidance Beliefs
04

Who can participate

The criteria were revised on the registry on Nov 18, 2026. See what changed

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 to 60 years.
  • Chronic non-specific low back pain persisting for at least 12 weeks.
  • Ability to understand study procedures and participate in assessments and exercise sessions.
  • Provision of written .

Exclusion criteria

Exclusion Criteria:

  • Spinal fracture or strong suspicion of vertebral fracture.
  • Known or suspected spinal or vertebral infection.
  • Active inflammatory spinal disease.
  • Progressive neurological deficits or signs and symptoms suggestive of cauda equina syndrome.
  • Significant spinal instability.
  • Severe osteoporosis or history of fragility fracture.
  • Recent spinal surgery.
  • Pregnancy.
  • Unexplained severe systemic symptoms or other clinical red flags requiring medical evaluation.
  • Any clinical condition that contraindicates or prevents the safe application of spinal mobilization or therapeutic exercise.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Standard Exercise Therapy Group

    Participants in this group will receive a standardized six-week exercise and education program. The program will consist of three exercise sessions per week, including two physiotherapist-supervised sessions and one home-based session (18 sessions in total). Each session will last approximately 45-60 minutes and include trunk motor control exercises, abdominal activation, bridging, bird-dog exercises, hip abductor strengthening, controlled lumbar mobility, sit-to-stand exercises, walking, and cool-down exercises. Exercise intensity and repetitions will be progressively adjusted according to individual tolerance. No spinal mobilization or manipulation will be performed.

    Other: Standard Exercise Therapy

  • Experimental
    Standard Exercise Therapy Plus Spinal Mobilization Group

    Participants in this group will receive the same standardized six-week exercise and education program as the active comparator group, consisting of two supervised sessions and one home-based session per week. Additionally, participants will receive non-thrust spinal mobilization targeting the lumbar or lumbopelvic region, performed by a trained physiotherapist once weekly for six weeks (six mobilization sessions in total). Each mobilization session will last approximately 10-15 minutes. The mobilization technique and target region will be selected based on clinical assessment and individual tolerance. High-velocity, low-amplitude (HVLA) spinal manipulation will not be performed.

    Other: Spinal Mobilization · Other: Standard Exercise Therapy

Interventions

  • OtherSpinal Mobilization

    Participants in the experimental group will receive non-thrust spinal mobilization in addition to standard exercise therapy. Mobilization will target the lumbar or lumbopelvic region and will be performed by a trained physiotherapist using Maitland-based oscillatory techniques. The target region and mobilization grade will be selected according to clinical assessment, symptom response, and individual tolerance. Mobilization will be administered once weekly for six consecutive weeks, with each session lasting approximately 10-15 minutes (six sessions in total). The mobilization technique, grade, duration, and participant response will be recorded.

  • OtherStandard Exercise Therapy

    Both groups will receive the same standardized six-week exercise and education program, consisting of three sessions per week (two physiotherapist-supervised sessions and one home-based session), for a total of 18 sessions. Each session will last approximately 45-60 minutes and include warm-up exercises, abdominal muscle activation, bridging, bird-dog exercises, hip abductor strengthening, controlled lumbar mobility exercises, sit-to-stand exercises, walking, and cool-down exercises. Exercise volume will be progressively increased every two weeks according to individual tolerance and movement quality. Strengthening exercises will generally progress from 2 sets of 10 repetitions to 2 sets of 15 repetitions, while walking duration will increase from 10 to 20 minutes. Exercise adherence, perceived exertion, and symptom responses will be monitored throughout the intervention.

06

What researchers measure

Primary outcomes

  1. Functional Disability Assessed Using the Roland-Morris Disability Questionnaire (RMDQ)

    Functional disability will be assessed using the Roland-Morris Disability Questionnaire (RMDQ), a 24-item questionnaire designed to evaluate disability related to low back pain. Total scores range from 0 to 24, with higher scores indicating greater functional disability. The primary endpoint will be the RMDQ score at Week 6, compared between groups after adjustment for baseline RMDQ scores.

    Time frame: Baseline (Week 0) and post-intervention (Week 6) and three-month follow-up (Week 18)

Secondary outcomes

  1. Pain Intensity Assessed Using the Visual Analog Scale (VAS)

    Pain intensity will be assessed using a 100-mm Visual Analog Scale (VAS). Participants will rate their average low back pain intensity over the preceding seven days, ranging from 0 mm (no pain) to 100 mm (worst imaginable pain). Higher scores indicate greater pain intensity.

    Time frame: Baseline (Week 0), post-intervention (Week 6), and three-month follow-up (Week 18)

  2. Fear-avoidance beliefs measured using the Fear-Avoidance Beliefs Questionnaire (FABQ)

    Fear-avoidance beliefs will be evaluated using the Fear-Avoidance Beliefs Questionnaire (FABQ), including physical activity and work subscales. Higher scores indicate greater fear-avoidance beliefs.

    Time frame: Baseline (Week 0), post-intervention (Week 6), and three-month follow-up (Week 18)

  3. Lumbar range of motion

    Lumbar flexion, extension, lateral flexion, and rotation will be measured using a universal goniometer. Three measurements will be obtained for each movement, and the mean value will be used for analysis.

    Time frame: Baseline (Week 0), post-intervention (Week 6), and three-month follow-up (Week 18)

07

Study locations

1 site
  • Ozel Mediworld
    Istanbul, 34744, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2026; primary completion for Feb 2027, 1 month later.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 1 month is below that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: start Aug 2026 → Dec 2026, primary completion Nov 2026 → Feb 2027 and completion Nov 2026 → Apr 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 23, 2026
First posted
Aug 6, 2026
StartEst.
Dec 21, 2026was Aug 2026
Primary completionEst.
Feb 1, 2027was Nov 2026
CompletionEst.
Apr 30, 2027was Nov 2026
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Aug 30, 2026→Dec 21, 2026
Nov 18, 2026
Primary completion
Nov 15, 2026→Feb 1, 2027
Nov 18, 2026
Study completion
Nov 30, 2026→Apr 30, 2027
Nov 18, 2026
Enrollment
30→60
Nov 18, 2026
Eligibility
Maximum age 65 Years→60 Years; 1 inclusion criterion edited, 2 added, 3 removed; 3 exclusion criteria edited, 6 added, 5 removed
What changed in the criteria
Inclusion criteria
  • EditedDiagnosis ofChronic non-specific low back pain persisting for at least 12 weeks.
  • RemovedSymptoms persisting for more than 12 weeks.
  • RemovedAble to understand the study procedures and provide written informed consent.
  • RemovedWilling to participate in the study and comply with the intervention protocol
  • AddedAbility to understand study procedures and participate in assessments and exercise sessions.
  • AddedProvision of written informed consent.
Exclusion criteria
  • AddedSpinal fracture or strong suspicion of vertebral fracture.
  • AddedKnown or suspected spinal malignancy or vertebral infection.
  • EditedInflammatoryActive inflammatory spinal diseasesdisease.
  • RemovedNeurological disorders or neurological deficits.
  • RemovedPsychiatric disorders.
  • AddedProgressive neurological deficits or signs and symptoms suggestive of cauda equina syndrome.
  • EditedStructuralSignificant spinal abnormalitiesinstability.
  • RemovedSpinal infection or tumor.
  • AddedSevere osteoporosis or history of fragility fracture.
  • EditedHistory of recentRecent spinal surgery.
  • RemovedChronic or systemic diseases that could affect participation.
  • RemovedConditions that could interfere with adherence to the treatment protocol
  • AddedUnexplained severe systemic symptoms or other clinical red flags requiring medical evaluation.
  • AddedAny clinical condition that contraindicates or prevents the safe application of spinal mobilization or therapeutic exercise.
Nov 18, 2026
Interventions
Changed Spinal Mobilization and Manipulation→Spinal Mobilization. Added Standard Exercise Therapy; removed Conventional Physiotherapy. Arms added: Standard Exercise Therapy Group·Standard Exercise Therapy Plus Spinal Mobilization Group; arms removed: Conventional Physiotherapy Group·Conventional Physiotherapy + Spinal Mobilization and Manipulation Group
Nov 18, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • ChangedBefore Pain intensity measured using the Visual Analog Scale (VAS)Now Functional Disability Assessed Using the Roland-Morris Disability Questionnaire (RMDQ)Time frame: Baseline and after 6 weeks of intervention → Baseline (Week 0) and post-intervention (Week 6) and three-month follow-up (Week 18)
Nov 18, 2026
Secondary outcomes
1 edited, 2 time frame changed
What changed in the outcomes
  • ChangedBefore Functional disability measured using the Roland-Morris Disability Questionnaire (RMDQ)Now Pain Intensity Assessed Using the Visual Analog Scale (VAS)Time frame: Baseline and after 6 weeks of intervention → Baseline (Week 0), post-intervention (Week 6), and three-month follow-up (Week 18)
  • Time frameFear-avoidance beliefs measured using the Fear-Avoidance Beliefs Questionnaire (FABQ)Baseline and after 6 weeks of intervention → Baseline (Week 0), post-intervention (Week 6), and three-month follow-up (Week 18)
  • Time frameLumbar range of motionBaseline and after 6 weeks of intervention → Baseline (Week 0), post-intervention (Week 6), and three-month follow-up (Week 18)
Nov 18, 2026
Title
Spinal Mobilization and ManipulationAdded to Exercise Therapy for NonspecificChronic Non-Specific Low Back Pain
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Start date Aug 30, 2026→Dec 21, 2026
    Primary completion Nov 15, 2026→Feb 1, 2027
    Study completion Nov 30, 2026→Apr 30, 2027
    Enrollment 30→60
    Eligibility Maximum age 65 Years→60 Years; 1 inclusion criterion edited, 2 added, 3 removed; 3 exclusion criteria edited, 6 added, 5 removed
    What changed in the criteria
    Inclusion criteria
    • EditedDiagnosis ofChronic non-specific low back pain persisting for at least 12 weeks.
    • RemovedSymptoms persisting for more than 12 weeks.
    • RemovedAble to understand the study procedures and provide written informed consent.
    • RemovedWilling to participate in the study and comply with the intervention protocol
    • AddedAbility to understand study procedures and participate in assessments and exercise sessions.
    • AddedProvision of written informed consent.
    Exclusion criteria
    • AddedSpinal fracture or strong suspicion of vertebral fracture.
    • AddedKnown or suspected spinal malignancy or vertebral infection.
    • EditedInflammatoryActive inflammatory spinal diseasesdisease.
    • RemovedNeurological disorders or neurological deficits.
    • RemovedPsychiatric disorders.
    • AddedProgressive neurological deficits or signs and symptoms suggestive of cauda equina syndrome.
    • EditedStructuralSignificant spinal abnormalitiesinstability.
    • RemovedSpinal infection or tumor.
    • AddedSevere osteoporosis or history of fragility fracture.
    • EditedHistory of recentRecent spinal surgery.
    • RemovedChronic or systemic diseases that could affect participation.
    • RemovedConditions that could interfere with adherence to the treatment protocol
    • AddedUnexplained severe systemic symptoms or other clinical red flags requiring medical evaluation.
    • AddedAny clinical condition that contraindicates or prevents the safe application of spinal mobilization or therapeutic exercise.
    Primary outcomes 1 edited
    What changed in the outcomes
    • ChangedBefore Pain intensity measured using the Visual Analog Scale (VAS)Now Functional Disability Assessed Using the Roland-Morris Disability Questionnaire (RMDQ)Time frame: Baseline and after 6 weeks of intervention → Baseline (Week 0) and post-intervention (Week 6) and three-month follow-up (Week 18)
    Secondary outcomes 1 edited, 2 time frame changed
    What changed in the outcomes
    • ChangedBefore Functional disability measured using the Roland-Morris Disability Questionnaire (RMDQ)Now Pain Intensity Assessed Using the Visual Analog Scale (VAS)Time frame: Baseline and after 6 weeks of intervention → Baseline (Week 0), post-intervention (Week 6), and three-month follow-up (Week 18)
    • Time frameFear-avoidance beliefs measured using the Fear-Avoidance Beliefs Questionnaire (FABQ)Baseline and after 6 weeks of intervention → Baseline (Week 0), post-intervention (Week 6), and three-month follow-up (Week 18)
    • Time frameLumbar range of motionBaseline and after 6 weeks of intervention → Baseline (Week 0), post-intervention (Week 6), and three-month follow-up (Week 18)
    Interventions Changed Spinal Mobilization and Manipulation→Spinal Mobilization. Added Standard Exercise Therapy; removed Conventional Physiotherapy. Arms added: Standard Exercise Therapy Group·Standard Exercise Therapy Plus Spinal Mobilization Group; arms removed: Conventional Physiotherapy Group·Conventional Physiotherapy + Spinal Mobilization and Manipulation Group
    Title Spinal Mobilization and ManipulationAdded to Exercise Therapy for NonspecificChronic Non-Specific Low Back Pain
    + 4 other changes: verification date, description, conditions and design details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07749898
Lead sponsor
Biruni University
Responsible party
alyildirim (Principal Investigator, Biruni University) — Principal investigator
First posted
Aug 6, 2026
Start date
Dec 21, 2026 (estimated)
Primary completion
Feb 1, 2027 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Ali Yıldırım, PhD
Contact
devri-alem-61@hotmail.com
+905399306460

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion